Výsledky vyhľadávania - "Toluidines/therapeutic use"
-
1
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: J Neurol
Journal of neurology, vol. 272, no. 8, pp. 491Predmety: Smoldering MS, Original Communication, PRLs, PIRA, Teriflunomide, Humans, Nitriles, Crotonates/therapeutic use, Crotonates/pharmacology, Hydroxybutyrates, Toluidines/therapeutic use, Toluidines/pharmacology, Female, Male, Adult, Antibodies, Monoclonal, Humanized/therapeutic use, Antibodies, Monoclonal, Humanized/pharmacology, Multiple Sclerosis, Relapsing-Remitting/drug therapy, Multiple Sclerosis, Relapsing-Remitting/diagnostic imaging, Multiple Sclerosis, Relapsing-Remitting/pathology, Middle Aged, Longitudinal Studies, Immunologic Factors/therapeutic use, Immunologic Factors/pharmacology, Brain/diagnostic imaging, Brain/pathology, Brain/drug effects, Disease Progression, Treatment Outcome, Diffusion Tensor Imaging, Magnetic Resonance Imaging, Follow-Up Studies, Disease-modifying therapies, Ocrelizumab
Popis súboru: application/pdf
-
2
Autori: a ďalší
Zdroj: Mahler, M R, Magyari, M, Pontieri, L, Elberling, F, Holm, R P, Weglewski, A, Poulsen, M B, Storr, L K, Bekyarov, P A, Illes, Z, Kant, M, Sejbaek, T, Stilund, M L, Rasmussen, P V, Brask, M, Urbonaviciute, I & Sellebjerg, F 2024, 'Prognostic factors for disease activity in newly diagnosed teriflunomide-treated patients with multiple sclerosis: a nationwide Danish study', Journal of Neurology, Neurosurgery and Psychiatry, vol. 95, no. 10, jnnp-2023-333265, pp. 979-987. https://doi.org/10.1136/jnnp-2023-333265
Mahler, M R, Magyari, M, Pontieri, L, Elberling, F, Holm, R P, Weglewski, A, Poulsen, M B, Storr, L K, Bekyarov, P A, Illes, Z, Kant, M, Sejbaek, T, Stilund, M L, Rasmussen, P V, Brask, M, Urbonaviciute, I & Sellebjerg, F 2024, 'Prognostic factors for disease activity in newly diagnosed teriflunomide-treated patients with multiple sclerosis : a nationwide Danish study', Journal of Neurology, Neurosurgery and Psychiatry, vol. 95, no. 10, pp. 979-987. https://doi.org/10.1136/jnnp-2023-333265Predmety: Male, Adult, Multiple Sclerosis, Toluidines, Denmark, Hydroxybutyrates, Cohort Studies, Disability Evaluation, 03 medical and health sciences, Multiple Sclerosis, Relapsing-Remitting, Sex Factors, 0302 clinical medicine, Recurrence, Crotonates/therapeutic use, Nitriles, Humans, Registries, 10. No inequality, Nitriles/therapeutic use, Age Factors, Middle Aged, Prognosis, Magnetic Resonance Imaging, Denmark/epidemiology, 3. Good health, Toluidines/therapeutic use, Crotonates, Multiple Sclerosis/drug therapy, Female, Relapsing-Remitting/drug therapy
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38569873
http://www.scopus.com/inward/record.url?scp=85190132357&partnerID=8YFLogxK
https://doi.org/10.1136/jnnp-2023-333265
https://vbn.aau.dk/da/publications/37d2eefb-0796-4c0a-b289-5d3e399fb3a1
https://portal.findresearcher.sdu.dk/da/publications/1f1ce4c3-dd8b-4557-98d8-ac3ddf41061c
https://doi.org/10.1136/jnnp-2023-333265
https://pure.au.dk/portal/en/publications/76064433-784c-4d00-99a1-a077fadd8e63
http://www.scopus.com/inward/record.url?scp=85190132357&partnerID=8YFLogxK
https://doi.org/10.1136/jnnp-2023-333265 -
3
Autori:
Zdroj: Przegląd Epidemiologiczny. 73(1):19-29
Predmety: Adult, Male, Scabies - pathology, Adolescent, Scabies - psychology, Permethrin - therapeutic use, Comorbidity, preschool, Anti-bacterial agents - therapeutic use, Histamine antagonists - therapeutic use, 80 and over, Humans, Child, Middle aged, Aged, Incidence, Pruritus, Scabies - drug therapy, Retrospective studies, Young adult, Scabies - epidemiology, Female, Toluidines - therapeutic use, Poland, Seasons, Social problems
-
4
Autori: a ďalší
Zdroj: Buron , M D , Chalmer , T A , Sellebjerg , F , Frederiksen , J , Góra , M K , Illes , Z , Kant , M , Mezei , Z , Petersen , T , Rasmussen , P V , Roshanisefat , H , Hassanpour-Kalam-Roudy , H , Sejbæk , T , Tsakiri , A , Weglewski , A , Sorensen , P S & Magyari , M 2019 , ' Comparative effectiveness of teriflunomide and dimethyl fumarate : A nationwide cohort study ' , Neurology , vol. 92 , no. 16 , pp. e1811-e1820 ....
Predmety: Adult, Cohort Studies, Crotonates/therapeutic use, Denmark, Dimethyl Fumarate/therapeutic use, Disability Evaluation, Female, Humans, Immunosuppressive Agents/therapeutic use, Male, Multiple Sclerosis, Relapsing-Remitting/drug therapy, Survival, Toluidines/therapeutic use, Treatment Outcome
-
5
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: Wolinsky, J S, Confavreux, C, Comi, G, Kappos, L, Olsson, T P, Benzerdjeb, H, Truffinet, P, Wang, L, Miller, A E, Freedman, M S, Stenager, E & Teriflunomide Multiple Sclerosis Oral (TEMSO) Trial Group 2011, ' Randomized trial of oral teriflunamide for relapsing multiple sclerosis ', The New England Journal of Medicine, vol. 2011, no. 365, pp. 1293-1303 . https://doi.org/10.1056/NEJMoa1014656
Predmety: Adult, Male, Oxidoreductases Acting on CH-CH Group Donors, Enzyme inhibitors - adverse effects, Disability evaluation, Toluidines, Dihydroorotate Dehydrogenase, Crotonates - adverse effects, Administration, Oral, Hydroxybutyrates, Crotonates - therapeutic use, Oxidoreductases acting on CH-CH group donors - antagonists & inhibitors, Multiple sclerosis, oral, Disability Evaluation, 03 medical and health sciences, Multiple Sclerosis, Relapsing-Remitting, 0302 clinical medicine, Nitriles, Fatigue - drug therapy, Secondary Prevention, Humans, Enzyme Inhibitors, Middle aged, Fatigue, Disease progression, Secondary prevention, Brain, Alanine Transaminase, relapsing-remitting - pathology, Middle Aged, relapsing-remitting - drug therapy, 3. Good health, Brain - pathology, Randomized trial, oral teriflunomide, multiple sclerosis, Young adult, Toluidines - adverse effects, Crotonates, Administration, Disease Progression, Toluidines - therapeutic use, Female, Enzyme inhibitors - therapeutic use, Alanine transaminase - blood
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/21991951
https://cris.maastrichtuniversity.nl/en/publications/3f1827f7-0f1f-4adf-96ff-921070105eff
https://doi.org/10.1056/NEJMoa1014656
http://residents.lsuhsc.edu/no/neurology/docs/Dec.%206%202012%20article.pdf
https://edoc.unibas.ch/30139/
https://www.nejm.org/doi/abs/10.1056/NEJMoa1014656
https://residents.lsuhsc.edu/no/neurology/docs/Dec.%206%202012%20article.pdf
https://researchportal.helsinki.fi/sv/publications/randomized-trial-of-oral-teriflunomide-for-relapsing-multiple-scl
https://europepmc.org/article/MED/21991951
https://hdl.handle.net/20.500.11768/13218
https://portal.findresearcher.sdu.dk/da/publications/d74b618b-fc66-4947-8310-c8f8d4eacba9
https://portal.findresearcher.sdu.dk/da/publications/d74b618b-fc66-4947-8310-c8f8d4eacba9
https://doi.org/10.1056/NEJMoa1014656
https://hdl.handle.net/11577/2486252
https://hdl.handle.net/2158/558333 -
6
Autori: a ďalší
Zdroj: MaineHealth Maine Medical Center
Predmety: Antiviral, COVID-19, Coronavirus, Multiple sclerosis, Teriflunomide, Adult, Aged, Betacoronavirus, Coronavirus Infections (complications), Crotonates (therapeutic use), Female, Humans, Hydroxybutyrates, Immunosuppressive Agents (therapeutic use), Male, Middle Aged, Multiple Sclerosis (complications, drug therapy), Nitriles, Pandemics, Pneumonia, Viral (complications), SARS-CoV-2, Toluidines (therapeutic use), Nervous System Diseases, Neurology, Virus Diseases
Relation: https://knowledgeconnection.mainehealth.org/mmc/3000; https://pubmed.ncbi.nlm.nih.gov/32494856/
-
7
Autori:
Zdroj: Swiss Medical Weekly, Vol 144, Iss 3940 (2014)
Swiss Medical Weekly, Vol. 144 (2014) P. w14012Predmety: 616.8, Daclizumab, Toluidines, Dimethyl Fumarate, Hydroxybutyrates, Interferon-beta/therapeutic use, Immunoglobulin G/therapeutic use, Antibodies, Monoclonal, Humanized, Multiple sclerosis, 03 medical and health sciences, Multiple Sclerosis, Relapsing-Remitting, 0302 clinical medicine, Fumarates, disease modifying therapies, Sphingosine, Crotonates/therapeutic use, Nitriles, Humans, fingolimod, interferon beta, Propylene Glycols/therapeutic use, Alemtuzumab, Fingolimod Hydrochloride, Fumarates/therapeutic use, Natalizumab, Interferon-beta, Multiple Sclerosis, Relapsing-Remitting/drug therapy, 16. Peace & justice, ddc:616.8, 3. Good health, Antibodies, Monoclonal, Humanized/therapeutic use, Toluidines/therapeutic use, Propylene Glycols, Crotonates, Immunoglobulin G, recommendations, glatiramer acetate, Immunosuppressive Agents/administration & dosage/adverse effects/therapeutic use, Medicine, Sphingosine/analogs & derivatives/therapeutic use, Immunosuppressive Agents
Popis súboru: application/pdf
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/25247669
https://doaj.org/article/330284a4b8404d99aaeac4a83e2bd7f4
https://core.ac.uk/display/74464289
https://pubmed.ncbi.nlm.nih.gov/25247669/
https://archive-ouverte.unige.ch/unige:89945
https://www.ncbi.nlm.nih.gov/pubmed/25247669
http://doi.emh.ch/smw.2014.14012
https://doi.emh.ch/smw.2014.14012
https://archive-ouverte.unige.ch/unige:89945
Full Text Finder
Nájsť tento článok vo Web of Science